Report Description

The global transgenic animal market is anticipated to observe an impressive growth during the forecast period, 2023-2027. The major factors include increasing consumption of animal-derived protein and dairy products and rise in R&D activities. A transgenic animal is one who's genes are modified to improve both quality and quantity of food demand and also help to understand gene disease. The other factors supporting the market's growth are rise various diseases, advancement in techniques, and growing awareness. Additionally, rising healthcare expenditure and implementation of the animal welfare regulations are driving the growth of the market in upcoming years.

Increasing Consumption of Animal-Derived Protein and Dairy Products

As protein and calcium plays a vital role in nutrition, the consumption of meat and meat products such as dairy products, eggs, beef, and chicken are increasing, which surge the market growth in foreseen years. For instance, genetically modified poultry, such as broilers, have high number of proteins which are easily digestible. Additionally, rapid urbanization and increase in population across the globe are bolstering the market growth. Owing to the increase in animal derived protein supplements and food products, the need for transgenic animals is also rising. Therefore, all these factors are propelling the growth of the transgenic animal market, globally. In 2015, a study by Meat and Livestock in Australia revealed that genetically modified cows can produce more milk and are less susceptible to cattle diseases.

Wide Applications of Transgenic Animals

Transgenic animals have numerous applications in various fields such as agriculture, medical and industrial sectors. They are used to develop new and improved strains of livestock and as model organisms. Development of transgenic farm animals are allowing more flexibility in direct genetic manipulation of livestock. With ever-growing world population and changing climate conditions, such efficient means of increasing food production are needed. In addition, transgenic animals are specifically designed to study the genes in order to develop a cure for the diseases such as Alzheimer’s and cancer. For instance, in 2020, Merck Animal Health along with Automazioni VX, Inc. (US) signed an agreement aiming to Innoject Pro, a newly designed subcutaneous chick vaccination technology. The technology will be utilized by coupling with Merck Animal Health’s Innovax range of vaccines, which aids for protection against infectious diseases.

Increasing awareness and R&D Initiatives

Various R&D initiatives and awareness programs are initiated by the governments of the respective countries, which is bolstering the growth of the transgenic market. As per a publication by the British Nutrition Foundation 2018, genetically modified cows were anticipated to produce milk without allergy-producing protein, which will make the product apt for lactose-intolerant people. As per the National Institute of Health, in 2017, approximately 8% of the population in the U.K. was suffering from lactose intolerance. Thus, the modifications are likely to provide newer prospects for animal genetics in the upcoming years. Furthermore, the rising initiative to educate on transgenic animal is further anticipated to drive the growth of this market.


Download Free Sample Report

Market Segmentation

The global transgenic animal market is segmented into product, PCR, technique, application, model organism, end user and company. Based on product, the market is divided into gene gun, PCR, microinjections, and others. Based on PCR, the market is divided into real-time PCR, digital PCR System, and others. Based on technique, the market is segmented into DNA microinjection, embryonic stem cell-mediated gene transfer, retrovirus-mediated gene transfer, and others. Based on application, the market is segmented into recombinant human proteins, monoclonal antibodies, xenotransplantation, and others. Based on model organisms, the market is segmented into mice, rabbit, cow, and others. Based on end user, the market is segmented into biotechnology & pharmaceutical companies, academic & research organizations, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising animal-based protein food and growing occurrence of diseases in the country.

Market Players Merck & Co., Inc., C.H. Boehringer Sohn Ko. KG, Randox Laboratories Limited, Zoetis, Inc., Virbac SA, Elanco Animal Health Inc., Biogénesis Bagó SA, Santa Cruz Biotechnology, Inc, Idexx Laboratories, Inc., and Innovative Diagnostics (IDVet) are some of the leading companies operating in the market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends

Segments covered

·         Product

o    PCR

·         Technique

·         Application

·         Model Organism

·         End User

·         Company

Regional scope

North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa

Key companies profiled

C.H. Boehringer Sohn Ko. KG, ELIAS Animal Health, LLC, Zoetis Inc., AB Science S.A., Karyopharm Therapeutics, Inc., Vivesto AB, Merial Inc., Elanco Animal Health, Inc., Dechra Pharmaceuticals PLC (Anivive Lifesciences), and Torigen Pharmaceuticals Inc

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global transgenic animal market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Transgenic Animal Market, By Product:

    • Gene Gun
    • PCR

§  Real-Time PCR

§  Digital PCR Systems

§  Others

    • Microinjections
    • Others   

·         Transgenic Animal Market, By Technique:

    • DNA Microinjection
    • Embryonic Stem Cell-Mediated Gene Transfer
    • Retrovirus-Mediated Gene Transfer
    • Others

·         Transgenic Animal Market, By Application:

    • Recombinant Human Proteins
    • Monoclonal Antibodies
    • Xenotransplantation
    • Others

·         Transgenic Animal Market, By Model Organisms:

    • Mice
    • Rabbit
    • Cow
    • Others

·         Transgenic Animal Market, By End User:

    • Biotechnology & Pharmaceutical Companies
    • Academic & Research Organizations
    • Others

·         Transgenic Animal Market, By Region:

    • North America
      • United States
      • Canada
      • Mexico
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • Europe & CIS
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Transgenic Animal Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Transgenic Animal Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Transgenic Animal Market

4.    Executive Summary

5.    Voice of Customer

6.    Clinical Trial Analysis

7.    Global Transgenic Animal Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product (Gene Gun, PCR, Microinjections, Others)

7.2.1.1.         By PCR (Real-Time PCR, Digital PCR Systems, Others)

7.2.2.     By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)

7.2.3.     By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)

7.2.4.     By Model Organisms (Mice, Rabbit, Cow, Others)

7.2.5.     By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)

7.2.6.     By Company (2021)

7.2.7.     By Region

7.3.  Product Market Map

8.    North America Transgenic Animal Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product (Gene Gun, PCR, Microinjections, Others)

8.2.1.1.         By PCR (Real-Time PCR, Digital PCR Systems, Others)

8.2.2.     By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)

8.2.3.     By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)

8.2.4.     By Model Organisms (Mice, Rabbit, Cow, Others)

8.2.5.     By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)

8.2.6.     By Country

8.3.  North America: Country Analysis

8.3.1.     United States Transgenic Animal Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product

8.3.1.2.2.             By Technique

8.3.1.2.3.             By Application

8.3.1.2.4.             By Model Organisms

8.3.1.2.5.             By End User

8.3.2.     Mexico Transgenic Animal Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product

8.3.2.2.2.             By Technique

8.3.2.2.3.             By Application

8.3.2.2.4.             By Model Organisms

8.3.2.2.5.             By End User

8.3.3.     Canada Transgenic Animal Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product

8.3.3.2.2.             By Technique

8.3.3.2.3.             By Application

8.3.3.2.4.             By Model Organisms

8.3.3.2.5.             By End User

9.    Europe Transgenic Animal Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Product (Gene Gun, PCR, Microinjections, Others)

9.2.1.1.         By PCR (Real-Time PCR, Digital PCR Systems, Others)

9.2.2.     By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)

9.2.3.     By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)

9.2.4.     By Model Organisms (Mice, Rabbit, Cow, Others)

9.2.5.     By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)

9.2.6.     By Country

9.3.  Europe: Country Analysis

9.3.1.     France Transgenic Animal Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product

9.3.1.2.2.             By Technique

9.3.1.2.3.             By Application

9.3.1.2.4.             By Model Organisms

9.3.1.2.5.             By End User

9.3.2.     Germany Transgenic Animal Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product

9.3.2.2.2.             By Technique

9.3.2.2.3.             By Application

9.3.2.2.4.             By Model Organisms

9.3.2.2.5.             By End User

9.3.3.     United Kingdom Transgenic Animal Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product

9.3.3.2.2.             By Technique

9.3.3.2.3.             By Application

9.3.3.2.4.             By Model Organisms

9.3.3.2.5.             By End User

9.3.4.     Italy Transgenic Animal Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Product

9.3.4.2.2.             By Technique

9.3.4.2.3.             By Application

9.3.4.2.4.             By Model Organisms

9.3.4.2.5.             By End User

9.3.5.     Spain Transgenic Animal Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Product

9.3.5.2.2.             By Technique

9.3.5.2.3.             By Application

9.3.5.2.4.             By Model Organisms

9.3.5.2.5.             By End User

10.  Asia-Pacific Transgenic Animal Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Product (Gene Gun, PCR, Microinjections, Others)

10.2.1.1.      By PCR (Real-Time PCR, Digital PCR Systems, Others)

10.2.2.  By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)

10.2.3.  By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)

10.2.4.  By Model Organisms (Mice, Rabbit, Cow, Others)

10.2.5.  By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)

10.2.6.  By Country

10.3.              Asia-Pacific: Country Analysis

10.3.1.  China Transgenic Animal Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product

10.3.1.2.2.           By Technique

10.3.1.2.3.           By Application

10.3.1.2.4.           By Model Organisms

10.3.1.2.5.           By End User

10.3.2.  India Transgenic Animal Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product

10.3.2.2.2.           By Technique

10.3.2.2.3.           By Application

10.3.2.2.4.           By Model Organisms

10.3.2.2.5.           By End User

10.3.3.  Japan Transgenic Animal Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product

10.3.3.2.2.           By Technique

10.3.3.2.3.           By Application

10.3.3.2.4.           By Model Organisms

10.3.3.2.5.           By End User

10.3.4.  South Korea Transgenic Animal Market Outlook

10.3.4.1.      Market Size & Forecast

10.3.4.1.1.           By Value

10.3.4.2.      Market Share & Forecast

10.3.4.2.1.           By Product

10.3.4.2.2.           By Technique

10.3.4.2.3.           By Application

10.3.4.2.4.           By Model Organisms

10.3.4.2.5.           By End User

10.3.5.  Australia Transgenic Animal Market Outlook

10.3.5.1.      Market Size & Forecast

10.3.5.1.1.           By Value

10.3.5.2.      Market Share & Forecast

10.3.5.2.1.           By Product

10.3.5.2.2.           By Technique

10.3.5.2.3.           By Application

10.3.5.2.4.           By Model Organisms

10.3.5.2.5.           By End User

10.3.6.  Vietnam Transgenic Animal Market Outlook

10.3.6.1.      Market Size & Forecast

10.3.6.1.1.           By Value

10.3.6.2.      Market Share & Forecast

10.3.6.2.1.           By Product

10.3.6.2.2.           By Technique

10.3.6.2.3.           By Application

10.3.6.2.4.           By Model Organisms

10.3.6.2.5.           By End User

10.3.7.  Indonesia Transgenic Animal Market Outlook

10.3.7.1.      Market Size & Forecast

10.3.7.1.1.           By Value

10.3.7.2.      Market Share & Forecast

10.3.7.2.1.           By Product

10.3.7.2.2.           By Technique

10.3.7.2.3.           By Application

10.3.7.2.4.           By Model Organisms

10.3.7.2.5.           By End User

10.3.8.  Singapore Transgenic Animal Market Outlook

10.3.8.1.      Market Size & Forecast

10.3.8.1.1.           By Value

10.3.8.2.      Market Share & Forecast

10.3.8.2.1.           By Product

10.3.8.2.2.           By Technique

10.3.8.2.3.           By Application

10.3.8.2.4.           By Model Organisms

10.3.8.2.5.           By End User

11.  South America Transgenic Animal Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Product (Gene Gun, PCR, Microinjections, Others)

11.2.1.1.      By PCR (Real-Time PCR, Digital PCR Systems, Others)

11.2.2.  By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)

11.2.3.  By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)

11.2.4.  By Model Organisms (Mice, Rabbit, Cow, Others)

11.2.5.  By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)

11.2.6.  By Country

11.3.              South America: Country Analysis

11.3.1.  Brazil Transgenic Animal Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Product

11.3.1.2.2.           By Technique

11.3.1.2.3.           By Application

11.3.1.2.4.           By Model Organisms

11.3.1.2.5.           By End User

11.3.2.  Argentina Transgenic Animal Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Product

11.3.2.2.2.           By Technique

11.3.2.2.3.           By Application

11.3.2.2.4.           By Model Organisms

11.3.2.2.5.           By End User

11.3.3.  Colombia Transgenic Animal Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Product

11.3.3.2.2.           By Technique

11.3.3.2.3.           By Application

11.3.3.2.4.           By Model Organisms

11.3.3.2.5.           By End User

11.3.4.  Chile Transgenic Animal Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Product

11.3.4.2.2.           By Technique

11.3.4.2.3.           By Application

11.3.4.2.4.           By Model Organisms

11.3.4.2.5.           By End User

12.  Middle East and Africa Transgenic Animal Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Product (Gene Gun, PCR, Microinjections, Others)

12.2.1.1.      By PCR (Real-Time PCR, Digital PCR Systems, Others)

12.2.2.  By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)

12.2.3.  By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)

12.2.4.  By Model Organisms (Mice, Rabbit, Cow, Others)

12.2.5.  By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)

12.2.6.  By Country

12.3.              MEA: Country Analysis

12.3.1.  South Africa Transgenic Animal Market Outlook

12.3.1.1.      Market Size & Forecast

12.3.1.1.1.           By Value

12.3.1.2.      Market Share & Forecast

12.3.1.2.1.           By Product

12.3.1.2.2.           By Technique

12.3.1.2.3.           By Application

12.3.1.2.4.           By Model Organisms

12.3.1.2.5.           By End User

12.3.2.  Saudi Arabia Transgenic Animal Market Outlook

12.3.2.1.      Market Size & Forecast

12.3.2.1.1.           By Value

12.3.2.2.      Market Share & Forecast

12.3.2.2.1.           By Product

12.3.2.2.2.           By Technique

12.3.2.2.3.           By Application

12.3.2.2.4.           By Model Organisms

12.3.2.2.5.           By End User

12.3.3.  UAE Transgenic Animal Market Outlook

12.3.3.1.      Market Size & Forecast

12.3.3.1.1.           By Value

12.3.3.2.      Market Share & Forecast

12.3.3.2.1.           By Product

12.3.3.2.2.           By Technique

12.3.3.2.3.           By Application

12.3.3.2.4.           By Model Organisms

12.3.3.2.5.           By End User

12.3.4.  Egypt Transgenic Animal Market Outlook

12.3.4.1.      Market Size & Forecast

12.3.4.1.1.           By Value

12.3.4.2.      Market Share & Forecast

12.3.4.2.1.           By Product

12.3.4.2.2.           By Technique

12.3.4.2.3.           By Application

12.3.4.2.4.           By Model Organisms

12.3.4.2.5.           By End User

12.3.5.  Turkey Transgenic Animal Market Outlook

12.3.5.1.      Market Size & Forecast

12.3.5.1.1.           By Value

12.3.5.2.      Market Share & Forecast

12.3.5.2.1.           By Product

12.3.5.2.2.           By Technique

12.3.5.2.3.           By Application

12.3.5.2.4.           By Model Organisms

12.3.5.2.5.           By End User

13.  Market Dynamics

13.1.              Drivers

13.2.              Challenges

14.  Market Trends & Developments

15.  Competitive Landscape (inclusive of SWOT Analysis)

15.1.              Merck & Co., Inc.

15.2.              C.H. Boehringer Sohn Ko. KG

15.3.              Randox Laboratories Limited

15.4.              Zoetis, Inc.

15.5.              Virbac SA

15.6.              Elanco Animal Health Inc.

15.7.              Biogénesis Bagó SA

15.8.              Santa Cruz Biotechnology, Inc

15.9.              Idexx Laboratories, Inc.

15.10.            Innovative Diagnostics (IDVet)

16.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Increasing consumption of animal-derived protein and dairy products and rise in R&D activities are driving the demand for the global transgenic animal market.

down-arrow

Market Players Merck & Co., Inc., C.H. Boehringer Sohn Ko. KG, Randox Laboratories Limited, Zoetis, Inc., Virbac SA, Elanco Animal Health Inc., Biogénesis Bagó SA, Santa Cruz Biotechnology, Inc, Idexx Laboratories, Inc., and Innovative Diagnostics (IDVet) are the key players operating in the global transgenic animal market.

down-arrow

Strict rules of government and the policies so put forward by the FDA act as a restraining factor affecting transgenic animals market growth. Also, the rise in developmental costs and reluctance in accepting transgenic products deteriorates the market size during the market forecast period.

down-arrow

The Global Transgenic Animal Market is studied from 2017 to 2027.

profile

Sakshi Bajaal

Business Consultant
Press Release

Transgenic Animal Market to be dominated by Growing Consumption of Animal-derived Protein and Dairy Products through 2027

Sep, 2022

Growing consumption of animal-derived protein and rise in R&D activities to drive the transgenic animal market in the forecast period, 2023-2027.